Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	609.20M +40.0%
Revenue (ttm)	228.94M +29.0%
Net Income	9.95M +40.3%
EPS	0.05 +39.1%
Shares Out	216.80M
PE Ratio	62.17
Forward PE	20.61
Dividend	0.03 (1.02%)
Ex-Dividend Date	May 28, 2026

Volume	1,270,147
Open	281.00
Previous Close	281.00
Day's Range	280.50 - 281.02
52-Week Range	187.00 - 284.50
Beta	0.70
Analysts	Buy
Price Target	290.00 (+3.2%)
Earnings Date	Sep 15, 2026

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants. The company also provides collagens, bone substitutes, resorbable fixation systems, vascular temporary occlusion, dressi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 1,800
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2025, AIM:AMS's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.

Analyst Summary

According to 8 analysts, the average rating for AMS stock is "Buy." The 12-month stock price target is 290p, which is an increase of 3.20% from the latest price.

Price Target

290p

(3.20% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 17, 2026

Data Sources Report a data error